188 related articles for article (PubMed ID: 29033934)
1. Ebi3 Prevents
Medina TS; Oliveira GG; Silva MC; David BA; Silva GK; Fonseca DM; Sesti-Costa R; Frade AF; Baron MA; Ianni B; Pereira AC; Chevillard C; Cunha-Neto E; Marin-Neto JA; Silva JS
Front Immunol; 2017; 8():1213. PubMed ID: 29033934
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-induced gene 3 suppresses T helper type 1, type 17 and type 2 immune responses after Trypanosoma cruzi infection and inhibits parasite replication by interfering with alternative macrophage activation.
Böhme J; Roßnagel C; Jacobs T; Behrends J; Hölscher C; Erdmann H
Immunology; 2016 Mar; 147(3):338-48. PubMed ID: 26694585
[TBL] [Abstract][Full Text] [Related]
3. Regulatory effects of IL-18 on cytokine profiles and development of myocarditis during Trypanosoma cruzi infection.
Esper L; Utsch L; Soriani FM; Brant F; Esteves Arantes RM; Campos CF; Pinho V; Souza DG; Teixeira MM; Tanowitz HB; Vieira LQ; Machado FS
Microbes Infect; 2014 Jun; 16(6):481-90. PubMed ID: 24704475
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of Cardiac IL-10 and Downregulation of IFN-
da Silva MV; de Almeida VL; de Oliveira WD; Matos Cascudo NC; de Oliveira PG; da Silva CA; da Silva ACS; Dos Reis Monteiro MLG; Correa RRM; Oliveira MAP; Lino-Júnior RS; Celes MRN; Machado JR
Mediators Inflamm; 2018; 2018():3421897. PubMed ID: 30622430
[TBL] [Abstract][Full Text] [Related]
5. Neurodegeneration and increased production of nitrotyrosine, nitric oxide synthase, IFN-gamma and S100beta protein in the spinal cord of IL-12p40-deficient mice infected with Trypanosoma cruzi.
Bombeiro AL; D'Império Lima MR; Chadi G; Alvarez JM
Neuroimmunomodulation; 2010; 17(2):67-78. PubMed ID: 19923851
[TBL] [Abstract][Full Text] [Related]
6. The Blockade of Interleukin-2 During the Acute Phase of
Nihei J; Cardillo F; Mengel J
Front Cell Infect Microbiol; 2021; 11():758273. PubMed ID: 34869064
[No Abstract] [Full Text] [Related]
7. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection.
Abel LC; Rizzo LV; Ianni B; Albuquerque F; Bacal F; Carrara D; Bocchi EA; Teixeira HC; Mady C; Kalil J; Cunha-Neto E
J Autoimmun; 2001 Aug; 17(1):99-107. PubMed ID: 11488642
[TBL] [Abstract][Full Text] [Related]
8. Disease Tolerance and Pathogen Resistance Genes May Underlie
Chevillard C; Nunes JPS; Frade AF; Almeida RR; Pandey RP; Nascimento MS; Kalil J; Cunha-Neto E
Front Immunol; 2018; 9():2791. PubMed ID: 30559742
[TBL] [Abstract][Full Text] [Related]
9. Trypanosoma cruzi-specific IFN-γ-producing cells in chronic Chagas disease associate with a functional IL-7/IL-7R axis.
Natale MA; Cesar G; Alvarez MG; Castro Eiro MD; Lococo B; Bertocchi G; Albareda MC; Laucella SA
PLoS Negl Trop Dis; 2018 Dec; 12(12):e0006998. PubMed ID: 30517089
[TBL] [Abstract][Full Text] [Related]
10. Deficient regulatory T cell activity and low frequency of IL-17-producing T cells correlate with the extent of cardiomyopathy in human Chagas' disease.
Guedes PM; Gutierrez FR; Silva GK; Dellalibera-Joviliano R; Rodrigues GJ; Bendhack LM; Rassi A; Rassi A; Schmidt A; Maciel BC; Marin Neto JA; Silva JS
PLoS Negl Trop Dis; 2012; 6(4):e1630. PubMed ID: 22545173
[TBL] [Abstract][Full Text] [Related]
11. Dogs infected with the blood trypomastigote form of Trypanosoma cruzi display an increase expression of cytokines and chemokines plus an intense cardiac parasitism during acute infection.
de Souza SM; Vieira PM; Roatt BM; Reis LE; da Silva Fonseca K; Nogueira NC; Reis AB; Tafuri WL; Carneiro CM
Mol Immunol; 2014 Mar; 58(1):92-7. PubMed ID: 24317279
[TBL] [Abstract][Full Text] [Related]
12. [Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].
Laucella SA; Rottenberg ME; de Titto EH
Rev Argent Microbiol; 1996; 28(2):99-109. PubMed ID: 8768488
[TBL] [Abstract][Full Text] [Related]
13. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; Antúnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
14. Development of chronic cardiomyopathy in canine Chagas disease correlates with high IFN-gamma, TNF-alpha, and low IL-10 production during the acute infection phase.
Guedes PM; Veloso VM; Afonso LC; Caliari MV; Carneiro CM; Diniz LF; Marques-da-Silva EA; Caldas IS; Do Valle Matta MA; Souza SM; Lana M; Chiari E; Galvão LM; Bahia MT
Vet Immunol Immunopathol; 2009 Jul; 130(1-2):43-52. PubMed ID: 19211152
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-32
Braga YLL; Neto JRC; Costa AWF; Silva MVT; Silva MV; Celes MRN; Oliveira MAP; Joosten LAB; Ribeiro-Dias F; Gomes RS; Machado JR
J Immunol Res; 2022; 2022():7070301. PubMed ID: 35097133
[TBL] [Abstract][Full Text] [Related]
16. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
Hoft DF; Lynch RG; Kirchhoff LV
J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
[TBL] [Abstract][Full Text] [Related]
17. Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage.
Medeiros GA; Silvério JC; Marino AP; Roffê E; Vieira V; Kroll-Palhares K; Carvalho CE; Silva AA; Teixeira MM; Lannes-Vieira J
Microbes Infect; 2009 Feb; 11(2):264-73. PubMed ID: 19100857
[TBL] [Abstract][Full Text] [Related]
18. Trypanosoma cruzi trans-sialidase prevents elicitation of Th1 cell response via interleukin 10 and downregulates Th1 effector cells.
Ruiz Díaz P; Mucci J; Meira MA; Bogliotti Y; Musikant D; Leguizamón MS; Campetella O
Infect Immun; 2015 May; 83(5):2099-108. PubMed ID: 25754197
[TBL] [Abstract][Full Text] [Related]
19. Regulatory Lymphoid and Myeloid Cells Determine the Cardiac Immunopathogenesis of
Fresno M; Gironès N
Front Microbiol; 2018; 9():351. PubMed ID: 29545782
[TBL] [Abstract][Full Text] [Related]
20. Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production.
Zhang L; Tarleton RL
Eur J Immunol; 1996 Jan; 26(1):102-9. PubMed ID: 8566051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
